US BROKER MOVES: AMAT upgraded at Mizuho; WAL downgraded at JPMorgan

Mizuho's upgrade of Applied Materials (AMAT) to Outperform signals growing confidence in its growth prospects, potentially aligning with positive sentiment in the semiconductor sector.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

One firm is considering a US IG sale for Wednesday, according to a Bloomberg survey

Amphenol Corporation (APH) Q4 2025 (USD): Adj. EPS 0.97 (exp. 0.93), Revenue 6.44bln (exp. 6.19bln); Q1 sales view 6.9-7bln (exp. 6.55bln), Adj. EPS 0.91-0.93 (exp. 0.88),

US BROKER MOVES: AMAT upgraded at Mizuho; WAL downgraded at JPMorgan

GE Vernova (GEV) expect Y/Y growth in gas equipment orders in Q1 for the power unit; failure to install 11 turbines could cut 2026 wind revenue by c. USD 250mln - conference call

US PRE-MARKET MOVERS: MSFT/META/TSLA, NVDA, AMZN, AI, AMAT, RGNX, STX, TXN, ASML, SBUX, T, PPG, ELV, QRVO

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • Applied Materials (AMAT) Upgraded to Outperform at Mizuho Securities
  • Circle Internet (CRCL) Upgraded to Neutral at Mizuho Securities
  • Energy Fuels (EFR CN) Upgraded to Neutral at Roth Capital Partners
  • Johnson & Johnson (JNJ) Upgraded to Overweight at Morgan Stanley
  • KKR & Co. (KKR) Upgraded to Buy at HSBC; PT USD 144
  • Korro Bio, Inc. (KRRO) Upgraded to Outperform at Oppenheimer; PT USD 22
  • Korro Bio, Inc. (KRRO) Upgraded to Overweight at Cantor
  • Microchip (MCHP) Upgraded to Buy at BofA; PT USD 95
  • Nextpower (NXT) Upgraded to Overweight at KeyBanc; PT USD 142
  • Texas Instruments (TXN) Upgraded to Neutral at BofA; PT USD 235
  • Visa (V) Upgraded to Buy at Rothschild & Co Redburn; PT USD 385

DOWNGRADES

  • Array (ARRY) Downgraded to Neutral at Baird; PT USD 11
  • BJ's Wholesale (BJ) Downgraded to Hold at Jefferies; PT USD 90
  • Brown & Brown (BRO) Downgraded to Neutral at Citi; PT USD 83
  • Capital City Bank (CCBG) Downgraded to Market Perform at KBW; PT USD 45
  • Martin Marietta (MLM) Downgraded to Hold at Loop Capital; PT USD 690
  • Nucor (NUE) Downgraded to Neutral at UBS; PT USD 183
  • PayPal (PYPL) Downgraded to Sell at Rothschild & Co Redburn; PT USD 50
  • PRA Group (PRAA) Downgraded to Market Perform at Citizens
  • Roper (ROP) Downgraded to Hold at Stifel; PT USD 385
  • Roper (ROP) Downgraded to Market Perform at Oppenheimer
  • Western Alliance (WAL) Downgraded to Neutral at JPMorgan; PT USD 105

INITIATIONS

  • Aardvark Therapeutics (AARD) Initiated at New Buy at B Riley; PT USD 32
  • Altimmune (ALT) Initiated at New Overweight at Barclays; PT USD 20
  • Apellis Pharma (APLS) Initiated at New Equal-Weight at Barclays; PT USD 24
  • Ascendis Pharma (ASND) ADRs Initiated at New Overweight at Barclays; PT USD 342
  • Bloom Energy (BE) Initiated at New Equal-Weight at Barclays; PT USD 153
  • Bridgebio (BBIO) Initiated at New Overweight at Barclays; PT USD 157
  • Coinbase (COIN) Initiated at New Neutral at Baird; PT USD 240
  • Crescent Biopharma (CBIO) Reinstated Overweight at Piper Sandler
  • Dauch Corp. (AXL) American Axle Initiated at New Buy at BWS Financial; PT USD 17
  • Entrada Therapeutics (TRDA) Initiated at New Outperform at Oppenheimer; PT USD 21
  • FormFactor (FORM) Initiated at New Hold at Freedom Capital; PT USD 64
  • Futu Holdings (FUTU) ADRs Reinstated Outperform at CCB Intl; PT USD 250
  • GE Vernova (GEV) Initiated at New Buy at China Renaissance; PT USD 966
  • Gossamer Bio (GOSS) Initiated at New Overweight at Barclays; PT USD 9
  • HeartFlow (HTFL) Initiated at New Overweight at Wells Fargo; PT USD 38
  • Insmed (INSM) Initiated at New Overweight at Barclays; PT USD 231
  • Madrigal Pharma (MDGL) Initiated at New Overweight at Barclays; PT USD 964
  • MBX Biosciences (MBX) Initiated at New Overweight at Barclays
  • Nano Nuclear Energy (NNE) Initiated at New Buy at Texas Capital; PT USD 49
  • NuScale Power (SMR) Initiated at New Buy at Texas Capital; PT USD 23
  • Oklo (OKLO) Initiated at New Buy at Texas Capital; PT USD 138
  • Raymond James (RJF) Initiated at New Overweight at Barclays; PT USD 191
  • Rush Enterprises (RUSHA) Initiated at New Neutral at UBS; PT USD 70
  • Sagimet Biosciences (SGMT) Initiated at New Equal-Weight at Barclays; PT USD 8
  • Shattuck Labs (STTK) Initiated at New Overweight at Piper Sandler; PT USD 15
  • SiriusXM (SIRI) Initiated at New Neutral at MoffettNathanson LLC; PT USD 21
  • Spotify (SPOT) Initiated at New Neutral at MoffettNathanson LLC; PT USD 487
  • Tyra Biosciences (TYRA) Initiated at New Overweight at Barclays; PT USD 59
  • uniQure (QURE) Initiated at New Equal-Weight at Barclays; PT USD 31
  • Warner Music (WMG) Initiated at New Buy at MoffettNathanson LLC; PT USD 38
Context

Conversely, JPMorgan's downgrade of Western Alliance (WAL) to Neutral suggests a reassessment of risk, possibly reflecting headwinds in the financial sector. Traders should pay attention to how these adjustments might influence market sentiment and stock performance within their respective sectors.

Related headlines

The whole workspace, free to try.

Try it free